FDA Approves First Generic Tulathromycin for Cattle & Swine

USAgNet - 02/22/2021

The FDA has approved the first two generic tulathromycin injectable products for the treatment and control of certain diseases in both cattle and swine.

Both generic products, Macrosyn and Increxxa, are approved for indications such as the treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating dairy cattle, suckling calves, dairy calves and veal calves.

It also helps control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.


« Return to Home Page

Ag-Bag Plastic
Zabel Equipment